The global digital health market is on a trajectory few industries can match. Valued at over $420 billion in 2025 and projected to surge well beyond $1 trillion within a decade, health technology is no longer a niche sector — it is becoming the backbone of modern healthcare delivery worldwide. Telehealth platforms, AI-powered diagnostics, wearable devices, and digital therapeutics are crossing borders at speed, landing in markets as different as Tokyo, Nairobi, Berlin, and São Paulo.

But here is the challenge every health tech company scaling internationally faces: the technology may be borderless, but the communications landscape is not. Regulatory environments differ dramatically from one country to the next. Media ecosystems have their own priorities and gatekeepers. Patient and clinician audiences bring culturally specific expectations around trust, evidence, and authority. What resonates in the United States may fall flat — or worse, misfire — in Southeast Asia or the Middle East.

This is where global health tech PR and international health communications become mission-critical. A well-executed international PR strategy does more than secure press mentions. It builds the credibility and trust that health tech companies need to achieve market access, attract investment, and win adoption from clinicians and patients in every new geography they enter.

In this guide, we break down everything you need to know about building and executing a global health tech PR strategy — from navigating cross-border regulatory messaging to building thought leadership that travels across cultures.

What Is Global Health Tech PR?

Global health tech PR is the practice of strategically managing communications for health technology companies as they operate, expand, and compete across multiple international markets. It combines the discipline of traditional healthcare public relations — with its emphasis on accuracy, sensitivity, and regulatory compliance — with the complexity of international PR, which requires an understanding of regional media landscapes, cultural nuances, and market-specific stakeholders.

Health tech is a broad category. It encompasses digital health platforms, mobile health applications, wearable devices, AI-powered diagnostics, electronic health records, telemedicine services, and medical devices with embedded software. Each of these sub-sectors carries its own communications dynamics, and when you layer in a global footprint, the strategic requirements multiply quickly. A PR campaign for an AI diagnostic tool entering the EU market must navigate clinical evidence messaging, MDR compliance, and relationships with European health media — all simultaneously.

What distinguishes global health tech PR from general tech PR is the weight of trust. Healthcare technology must earn trust before it earns adoption. Clinicians, procurement committees, patients, and regulators all respond to clinical evidence, peer endorsement, and regulatory credibility — not marketing claims. Getting this communications balance right across multiple markets is the core challenge.

Why International Health Communications Matter Now

The scale of the opportunity in global health tech is hard to overstate. Multiple market research bodies peg the digital health sector at well over $350 billion in current value, with consensus forecasts pointing toward CAGR figures in the 19–23% range through the mid-2030s. North America currently holds the largest regional share, but Europe and Asia-Pacific are both expanding rapidly, driven by government digital health initiatives, growing smartphone penetration, and rising demand for remote patient monitoring.

This global expansion creates an urgent communications imperative. As health tech companies enter new markets, they face an audience that has never heard of them, may be skeptical of digital health solutions, and is already being courted by well-established local competitors and global giants alike. A robust international health communications strategy is the mechanism through which a company builds its reputation, earns media credibility, and establishes itself as a legitimate player in each new geography.

Beyond brand awareness, international health communications serve a structural business function. Positive media coverage in target markets supports fundraising narratives, strengthens relationships with local healthcare systems and procurement bodies, and signals to regulators that the company is a serious, transparent actor. In health tech, PR is not a nice-to-have. It is infrastructure.

The Unique Challenges of Global Health Tech PR

Global health tech PR is one of the most demanding communications disciplines for a reason. It sits at the intersection of three complex domains: healthcare, technology, and international communications. Understanding the specific challenges helps companies plan for them rather than be blindsided.

Regulatory Complexity Across Markets

Health technology market access is a country-by-country process. CE marking may open the EU, but reimbursement decisions are made at a national level. NHS procurement in the UK operates differently from Statutory Health Insurance procurement in Germany. FDA clearance in the United States does not automatically carry weight with regulators in Japan, Australia, or Brazil. Every market has its own approval pathway, its own regulatory language, and its own communications sensitivities around what companies can and cannot claim publicly about their products. A PR team without deep knowledge of these frameworks risks producing messaging that is inaccurate, non-compliant, or simply ineffective.

Cultural Differences in Health Communication

How audiences receive health information varies enormously across cultures. In some markets, patient empowerment narratives resonate strongly; in others, the authority of clinician endorsement carries far greater weight. The role of data privacy in health communications differs between a GDPR-governed European audience and markets with different data norms. Emotional storytelling around patient outcomes, which is a powerful PR tool in the US and UK, requires careful calibration in markets where discussing illness publicly carries stigma. Effective international health communications require local insight, not just translation.

Fragmented Media Ecosystems

There is no single global health tech media landscape. Each market has its own tier of trade publications, national health media outlets, business press, and emerging digital channels. A placement in STAT News carries enormous weight with US health tech audiences; it may be unknown to a healthcare procurement committee in the Netherlands. Building media relationships and achieving impactful coverage across multiple markets simultaneously requires genuine local expertise and established journalist relationships — not just a list of email addresses.

The Complexity of Scientific Claims

Health tech PR operates under a constraint that most other technology communications disciplines do not face. Clinical claims must be substantiated. Regulatory statements must be precise. Patient data must be handled with absolute care. In markets where regulatory bodies actively monitor health communications — and many do — an overstated efficacy claim in a press release can trigger enforcement action, damage regulatory relationships, and create a reputational crisis that takes years to recover from. The discipline required to communicate health technology innovations compellingly while staying within the bounds of what evidence supports is a specialized skill.

Building a Global Health Tech PR Strategy: Step by Step

A global health tech PR strategy is not simply a domestic strategy scaled up. It requires a fundamentally different architecture — one that balances global brand consistency with market-specific execution. Here is how to approach it.

1. Define your global narrative and market-specific adaptations — Your core brand story — what your technology does, why it matters, and what makes it different — must be consistent across all markets. This is your global narrative. But the way that story is told, the evidence it leans on, the stakeholders it addresses, and the media channels it uses must be adapted for each market. Think of it as a single musical score played by local orchestras. The composition is the same; the instrumentation changes.

2. Map the stakeholder landscape in each market — In health tech, your audiences extend well beyond the general public. They include clinicians, hospital procurement officers, health system administrators, regulators, investors, payers, and patient advocacy groups. Each of these stakeholders has different information needs and different levels of media consumption. A thorough stakeholder map for each target market is the foundation of an effective communications plan.

3. Prioritize markets strategically — Most health tech companies cannot execute full-scale PR campaigns in every market simultaneously. Prioritization should be driven by where regulatory approval is being sought, where commercial partnerships are developing, where the competitive environment is most active, and where media coverage would most directly support business objectives.

4. Build a localized media strategy — Identify the key publications, journalists, and digital channels in each priority market. Understand their editorial priorities, their preferred story formats, and the relationships they have with their audiences. Invest in genuine relationship-building rather than broadcast pitching. A single well-placed feature in the right national health trade publication can shift the perception of an entire market.

5. Develop a consistent content calendar with local triggers — A content calendar for global health tech PR should map your communications output against both your company milestones — funding rounds, product launches, regulatory approvals, clinical trial results — and market-specific news cycles. Health awareness months, national health policy announcements, and regional medical conferences all create earned media opportunities that a well-prepared PR team can activate quickly.

6. Measure and iterate — Set clear KPIs for each market, including media coverage volume and quality, share of voice against competitors, message penetration with target audiences, and downstream business metrics like inbound enquiries, partnership conversations, and investor interest. Review results regularly and adjust your approach based on what the data tells you.

Regulatory Messaging Across Borders

One of the highest-stakes elements of global health tech PR is getting regulatory messaging right. Every market has a different approval pathway, and the communications around regulatory milestones — whether that is FDA clearance, CE marking under the EU MDR, UKCA marking, or TGA approval in Australia — carries significant weight with investors, potential commercial partners, and healthcare system buyers. How you communicate these milestones, and to whom, can meaningfully accelerate or delay commercial traction.

The fundamental principle is precision. In regulated health tech communications, accuracy is non-negotiable. What the regulatory clearance or approval actually covers, what it does not cover, and what it means for clinical use in specific markets must be stated correctly every time. This requires PR professionals who understand the regulatory landscape well enough to catch errors in draft press releases before they go out — and who know when to involve regulatory affairs and legal teams in the communications review process.

Beyond accuracy, regulatory messaging should be positioned as a proof point in your broader credibility narrative. Clearances and approvals are not just compliance milestones; they are evidence that your technology has been subjected to independent scrutiny and found to meet the standards of serious regulatory bodies. That story, told well, is powerfully reassuring to every stakeholder in your value chain. This is especially important when entering markets where digital health adoption is still maturing and decision-makers are cautious about new entrants. PR services that combine deep sector knowledge with AI PR expertise are well placed to navigate this complexity, particularly as AI-powered health tools face increasingly specific regulatory scrutiny globally.

Thought Leadership in Global Health Tech

Thought leadership is arguably the most powerful long-term PR tool available to health tech companies expanding internationally. It works because it operates at the level of ideas rather than products. When your CEO or Chief Medical Officer is regularly published in respected health and technology publications across your target markets — contributing informed perspectives on AI in diagnostics, the future of remote patient monitoring, or the policy conditions for digital health adoption — your company earns a form of credibility that paid advertising simply cannot buy.

Effective health tech thought leadership has several defining characteristics. It is grounded in genuine expertise and original perspective, not rephrased industry consensus. It addresses the real concerns of its target audience — clinicians, investors, policymakers, or patients — rather than being thinly veiled product promotion. And it is consistent: a single thought leadership article has limited impact, but a sustained programme of well-placed contributions across multiple markets, over multiple months, builds a reputation that becomes a company asset.

For international expansion, thought leadership must be market-specific in its focus even when it draws on global evidence. An article on AI-assisted diagnostics pitched to a US health media outlet will land differently than the same core argument adapted for a UK NHS audience or a Middle Eastern healthcare publication. The underlying insight can be consistent; the framing, evidence selection, and reference points should reflect the specific context of each market. This kind of nuanced localization is a hallmark of sophisticated global health tech PR and is directly connected to broader AI PR strategy for companies operating in this space.

Media Relations in International Health Tech Markets

Securing meaningful media coverage in international health tech markets requires more than sending press releases to journalists you have never met. It requires an understanding of each market's media ecosystem, an ability to identify the stories that resonate with specific editorial communities, and the relationship capital to get those stories in front of the right people at the right time.

In practice, this means building genuine relationships with health and technology journalists across your priority markets — understanding their beats, following their coverage, engaging with their work, and providing them with useful information and expert perspectives even when you have no immediate news to announce. When you do have news, those established relationships are the difference between a pitch that gets opened and one that goes unread.

Media relations in health tech also requires an understanding of what different editorial communities consider newsworthy. Trade publications serving hospital procurement professionals want different content than general tech business media. National health policy publications have different story triggers than digital health investor newsletters. A global health tech PR team must be skilled at packaging the same underlying news for multiple distinct editorial audiences — and doing so in a way that feels native to each publication rather than obviously repurposed.

For health tech companies with ambitions in financial sectors or seeking investment coverage alongside health sector visibility, integrating PR efforts across verticals is important. Specialist agencies that offer complementary services like Fintech PR or Crypto PR can be valuable partners when health tech companies intersect with digital payment infrastructure, blockchain health records, or decentralized health data platforms.

Crisis Communications in Health Tech: A Global Perspective

In no sector is crisis communications more consequential than health technology. A data breach exposing patient records, a reported adverse event linked to a medical device, a regulatory warning letter, or a viral social media controversy around AI bias in diagnostics — any of these can escalate from a local incident to a global reputational crisis within hours. The interconnected nature of international media means that a story breaking in one market rarely stays there.

Effective crisis communications in global health tech requires preparation long before a crisis occurs. This means having clear protocols for how the organization responds publicly, who is authorized to speak, what the core messages are in different crisis scenarios, and how those messages need to be adapted for different regulatory environments and cultural contexts. A crisis statement that is appropriate and legally sound in the United States may require significant modification before it can be issued in the EU or Asia-Pacific, both due to regulatory language requirements and cultural expectations around corporate accountability.

Speed and transparency are universally important in health tech crisis communications, but the calibration differs by market. Having a PR partner with genuine on-the-ground knowledge in each of your key markets is not a luxury in these situations — it is operational necessity. The reputation you have built through years of consistent, credible communications is the most important buffer you have when a crisis hits. This is why ongoing reputation management and crisis preparedness are core components of any serious global health tech PR programme, and why companies in adjacent high-stakes sectors like GreenTech and LegalTech face similar imperatives when operating internationally.

Measuring Global Health Tech PR Success

One of the perennial challenges in PR is demonstrating value in terms that resonate with business leadership. In global health tech, this challenge is compounded by the complexity of operating across multiple markets with different media landscapes, different commercial objectives, and different timelines to impact. A robust measurement framework is essential.

At the output level, measurement tracks media coverage volume, quality, and reach across each target market; share of voice relative to competitors; message accuracy and penetration in coverage secured; and the prominence of executive spokespeople as sources and commentators. These metrics provide a clear picture of the PR programme's activity and immediate results.

At the outcomes level — which is where PR's real business value becomes visible — the metrics shift to changes in brand awareness and perception among target stakeholder groups, inbound interest from potential commercial partners or investors following PR activity, improvements in search visibility driven by earned media and backlinks, and the quality and frequency of speaking and thought leadership opportunities secured. For global health tech companies, tracking these metrics by market allows for meaningful comparison and strategic reallocation of PR investment toward the highest-performing geographies.

Why Partner with a Specialist Global Health Tech PR Agency

The complexity of global health tech PR — navigating regulatory messaging, building relationships across fragmented international media ecosystems, calibrating thought leadership for different cultural contexts, and managing the ever-present risk of a health-related communications crisis — is significant. Few in-house communications teams have the bandwidth, the market-specific relationships, or the breadth of sector expertise to execute at the level the opportunity demands.

A specialist global health tech PR agency brings several things that are difficult to replicate internally. It brings established media relationships in key markets, built through years of consistent, credible pitching and journalist engagement. It brings regulatory communications expertise, so your messaging stays accurate and compliant as it crosses borders. It brings a strategic perspective informed by working with multiple health tech clients across the full arc of their growth journeys — from early-stage market entry to established global presence. And it brings the agility to move quickly when news breaks, a clinical trial result lands, or a funding round is announced.

At SlicedBrand, we work with innovative technology companies at precisely these inflection points — helping them transform genuine breakthroughs into the kind of media presence and stakeholder credibility that drives commercial outcomes. Recognized by Business Insider as top PR pros in the tech industry, our team combines strategic storytelling with deep media relationships across global markets, delivering real coverage that exceeds expectations. Whether your health tech company is entering new markets, seeking to establish thought leadership, managing a complex regulatory communications challenge, or simply needs a PR partner who understands the unique demands of this sector, we are ready to help.

Conclusion

Global health tech is one of the most exciting and consequential sectors in the technology landscape today. The companies building the next generation of digital health tools have the potential to improve outcomes for millions of people across dozens of markets. But realizing that potential requires more than great technology — it requires the kind of credibility, trust, and visibility that only a well-executed international health communications strategy can deliver.

From navigating cross-border regulatory messaging and building localized thought leadership, to managing media relations across fragmented international ecosystems and preparing for the inevitable moments of crisis, global health tech PR is a discipline that rewards strategic investment and expert execution. The companies that get it right will find that their communications capability becomes a genuine competitive advantage — accelerating market access, attracting investment, and building the long-term brand equity that sustains growth across geographies.

If your health tech company is ready to take its international communications to the next level, the first step is a conversation with a PR partner who understands the terrain.